Invitae Corporation (NYSE: NVTA), a genetic information company, has announced that it has more than doubled the size of its genetic testing platform to include more than 600 genes and will begin ...
The first full day of preseason testing has offered the clearest glimpse yet of Formula 1’s radically new generation of cars. Early data suggests several teams may have discovered very different ways ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results